PT2950780T - Formulações farmacêuticas estabilizadas de análogos de insulina e/ou derivados de insulina - Google Patents

Formulações farmacêuticas estabilizadas de análogos de insulina e/ou derivados de insulina

Info

Publication number
PT2950780T
PT2950780T PT147025670T PT14702567T PT2950780T PT 2950780 T PT2950780 T PT 2950780T PT 147025670 T PT147025670 T PT 147025670T PT 14702567 T PT14702567 T PT 14702567T PT 2950780 T PT2950780 T PT 2950780T
Authority
PT
Portugal
Prior art keywords
insulin
pharmaceutical formulations
stabilized pharmaceutical
derivatives
analogues
Prior art date
Application number
PT147025670T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of PT2950780T publication Critical patent/PT2950780T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
PT147025670T 2013-02-04 2014-02-03 Formulações farmacêuticas estabilizadas de análogos de insulina e/ou derivados de insulina PT2950780T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13305126 2013-02-04
US201361761434P 2013-02-06 2013-02-06

Publications (1)

Publication Number Publication Date
PT2950780T true PT2950780T (pt) 2020-07-07

Family

ID=66013563

Family Applications (1)

Application Number Title Priority Date Filing Date
PT147025670T PT2950780T (pt) 2013-02-04 2014-02-03 Formulações farmacêuticas estabilizadas de análogos de insulina e/ou derivados de insulina

Country Status (5)

Country Link
JP (2) JP6698797B2 (es)
ES (1) ES2804719T3 (es)
PT (1) PT2950780T (es)
RU (1) RU2019128331A (es)
SG (1) SG10201913433SA (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2804719T3 (es) * 2013-02-04 2021-02-09 Sanofi Sa Formulaciones farmacéuticas estabilizadas de análogos de insulina y/o derivados de insulina
CN110721154A (zh) * 2019-10-28 2020-01-24 南京圣鼎医药科技有限公司 一种恩格列净口服溶液及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63107941A (ja) * 1985-11-28 1988-05-12 Wakunaga Pharmaceut Co Ltd 制ガン剤
JP5715418B2 (ja) * 2007-11-08 2015-05-07 ノボ・ノルデイスク・エー／エス インスリン誘導体
AR075998A1 (es) * 2009-04-01 2011-05-11 Genentech Inc Tratamiento de trastornos resistentes a insulina.composicion farmaceutica. uso. kit
CN102470165B (zh) * 2009-06-26 2014-12-24 诺沃-诺迪斯克有限公司 包含胰岛素、烟酰胺和氨基酸的制剂
CN103249427A (zh) * 2010-12-14 2013-08-14 诺沃—诺迪斯克有限公司 速效胰岛素联合长效胰岛素
MX340172B (es) * 2011-06-17 2016-06-28 Halozyme Inc Formulaciones estables de una enzima degradadora de hialuronano.
ES2804719T3 (es) * 2013-02-04 2021-02-09 Sanofi Sa Formulaciones farmacéuticas estabilizadas de análogos de insulina y/o derivados de insulina

Also Published As

Publication number Publication date
ES2804719T3 (es) 2021-02-09
RU2019128331A (ru) 2019-12-16
JP2020128395A (ja) 2020-08-27
SG10201913433SA (en) 2020-03-30
JP6698797B2 (ja) 2020-05-27
JP2019052162A (ja) 2019-04-04

Similar Documents

Publication Publication Date Title
ZA201504582B (en) Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
SG11201604710XA (en) Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
SG11201604708VA (en) Stabilized glycerol free pharmaceutical formulations of insulin analogues and/or insulin derivatives
IL274841A (en) A stabilized formulation with a controlled release of vitamin D, and methods for its administration
IL240290B (en) History of pyridazinone-amide and pharmaceutical preparations containing them
HK1225613A1 (zh) 賴谷胰島素的穩定製劑
SG11201604706TA (en) Stabilized pharmaceutical formulations of insulin aspart
EP4005604C0 (en) ADMINISTRATION OF MEDICINES
HK1221152A1 (zh) 用於呋塞米的皮下施用的藥物製劑
HK1218079A1 (zh) 亞硝酸鹽的藥物製劑及其用途
HK1211594A1 (en) Human relaxin analogue, pharmaceutical composition of same, and pharmaceutical application of same
IL240292A0 (en) History of quinazoline and pharmaceutical preparations containing them
SG10201913433SA (en) Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
GB201307082D0 (en) Pharmaceutical composition comprising 15-HETrE and methods of using the same
BR112015016331A2 (pt) formulação farmacêutica estabilizada e método de estabilização de uma composição compreendendo voriconazol
EP3072873A4 (en) Vitamin d analogues of pharmaceutical interest
GB201319437D0 (en) Delivery of drugs